Psilocybin trial reveals drug's efficacy in treating serious depression

South Africa News News

Psilocybin trial reveals drug's efficacy in treating serious depression
South Africa Latest News,South Africa Headlines
  • 📰 YahooNews
  • ⏱ Reading Time:
  • 67 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 30%
  • Publisher: 59%

The largest-ever study of the psychedelic drug psilocybin revealed that the drug is effective in treating serious depression.

The largest-ever study of the psychedelic drug psilocybin revealed Tuesday that the drug is effective in treating serious depression,The Compass Pathways study, which is the "largest randomized, controlled, double-blind trial of psilocybin," found that patients who were given the highest dose of the drug had a significant decrease in depressive symptoms as compared to the placebo group, per Stat.Subscribe for freeAbout 29.

The patients that received 25-milligram — the highest dose of the drug in the study — also experienced a "highly statistically significant and clinically relevant reduction in depressive symptom severity after three weeks," per Compass Pathways. Patients who received the lower 10-milligram dose did not experience a statistically significant difference after three weeks.The results of the study, which included 233 patients across Europe and North America, come after the Food and Drug Administration granted Compass Pathways a breakthrough therapy designation, paving the way for a potentially accelerated drug approval process, per Stat.The study also included data on patients who experienced adverse side effects from the drug.

Twelve patients reported treatment-emergent serious adverse events, including five who were in the 25-milligram group and six in the 10-milligram group. "The suicidal behaviors were reported at least one month after the administration of treatment and they occurred in patients who were essentially non-responding," Guy Goodwin, Compass’ chief medical officer, said Tuesday, per Stat.The results have not been published in a medical journal or peer-reviewed, according to Stat.Compass is in the early stages of beginning a Phase 3 trial next year, per Stat.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

YahooNews /  🏆 380. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Covid: Medication holiday may boost vaccine protectionCovid: Medication holiday may boost vaccine protectionA trial will look at how to protect patients against Covid who also need immunosuppressant drugs.
Read more »

Kyle Rittenhouse Judge Shouts Out Veterans in Court, Debatably Influences CaseKyle Rittenhouse Judge Shouts Out Veterans in Court, Debatably Influences CaseThe judge in the Kyle Rittenhouse trial did something that, on its face, seems pure and patriotic -- but, arguably it could also, unjustly, impact the outcome of the trial.
Read more »

7 Derm-Approved Tips for Clearing Up Painful Cystic Breakouts7 Derm-Approved Tips for Clearing Up Painful Cystic BreakoutsThese are the most effective ways to treat cystic acne without a cortisone shot.
Read more »

The Fitbit Luxe is on Major Sale Right NowThe Fitbit Luxe is on Major Sale Right NowThe Fitbit Luxe Is On Major Sale at Best Buy
Read more »

The Fitbit Luxe is on Major Sale Right NowThe Fitbit Luxe is on Major Sale Right NowTreat yourself to an early Christmas gift.
Read more »



Render Time: 2025-04-07 12:58:07